A Practical Approach to Veterinary Vaccine Development and Registration in the EU

This meeting has been designed to give practical advice and guidance on how to successfully develop market approval in the EU. The programme will take participants through a step-by-step approach to the process and will also provide key guidance on how to maintain MA once achieved.

10-11 Mar 2020

GBP 1,399 1,199 *
EUR 1,959 1,679 *
USD 2,182 1,870 *
* When you book before 14 Feb

Book now

Course overview

Demand for biologics in veterinary medicine is increasing. However, developing vaccines and successfully obtaining market authorisation brings its own complex and challenging issues.

This course has been designed to give practical advice and guidance on how to successfully develop a veterinary vaccine and achieve market approval in the EU, ensuring that participants gain a comprehensive insight into the necessary requirements.

The programme will take a step-by-step approach to the process and will include a workshop to help delegates gain a better understanding of the requirements in practice. There will be ample time for discussion throughout the two days with our expert faculty and fellow professionals.

Benefits of attending:

  • Recognise the key legislation and guidance and how to use this to plan an effective veterinary vaccine development
  • Understand what data you need to generate for your application and how to present this in your dossier
  • Gain an insight into the different routes to market and how to submit your dossier for market approval
  • Learn how and when to seek regulatory advice during development
  • Consider the implications of the ongoing review of the Veterinary Medicines Regulations

Book both

This meeting runs back-to-back with Registration of Veterinary Vaccines in the USA and Canada on 12 March 2020 and there is a £200/€280 discount off when booked together with this programme.

To register on both events events click HERE

To find out more call Customer Services on +44 (0)20 7749 4730 or e-mail info@management-forum.co.uk

*Sponsored by*

Who should attend

This event will be beneficial to all those working with veterinary vaccines from development to market approval.

The programme will be of particular interest to:

  • New entrants to registration departments
  • Veterinary medicinal product manufacturers
  • Registration managers
  • Research and development departments
  • Academics with an interest in commercialising opportunities
  • Personnel from micro/small and medium-sized enterprises (SMEs)

Programme - Day 1

A practical guide to the EU regulatory framework for veterinary vaccines

- Regulatory bodies
- Key legislation and guidance
- Update on the legislation review

Meeting the requirements of the marketing authorisation dossier – Part 2: Quality

- Legislation and guidance
- Layout and content of the Part 2 dossier

Meeting the requirements of the marketing authorisation dossier – Part 3: Safety

- Legislation and guidance
- Data requirements for the demonstration of safety
- Layout of the Part 3 dossier

Meeting the requirements of the marketing authorisation dossier – Part 4: Efficacy

- Legislation and guidance
- Data requirements for the demonstration of efficacy
- Layout of the Part 4 dossier

Using the summary of product characteristics (SmPC) as a tool for development

Programme - Day 2

Planning a vaccine development – introduction and workshop

Workshop – groups report back and Q&A

Seeking regulatory advice and development of novel vaccines

- Meetings with regulators
- Scientific advice
- Innovation Task Force (ITF)

Procedures aimed at promoting innovation and vaccine availability

- Minor use/minor species (MUMS) classification
- Small/medium enterprise (SME) designation
- EMA network strategy 2020

Preparing the dossier submission

- Marketing authorisation dossier – Part 1: Administrative documentation, DACS and benefit risk assessments and product information
- Tips on dossier writing and e-submissions

European licensing procedures and regulatory strategy

- Centralised procedure
- Decentralised procedure
- Mutual recognition procedure
- Regulatory strategy

Presenters

Mel Munro

Dr Mel Munro has worked as a consultant in veterinary medicinal product development and registration since 2002. She provides regulatory advice on all areas of VMP development taking ideas for veterinary medicines from proof of concept right through to Marketing Authorisations (MA). On a day-to-day basis, she advises on regulatory strategy, performs technical due diligence and gap analyses and prepares strategic development plans and expert reports. She is also experienced in negotiation with the regulators, preparing reports, documents and dossiers to support MA submissions as well as managing regulatory procedures and assisting clients with regulatory referrals. Over her career she has been involved in various biologicals development projects ranging from more ‘conventional’ vaccines to novel biologicals containing products of rDNA technology and GMO’s.

Tamsin Dawson

Dr Tamsin Dawson has worked in the development and regulation of animal health products since 2005, having started her career in analytical method development. In her current role at the veterinary product development consultancy group, Triveritas, she supports clients on a range of veterinary vaccine, pharmaceutical, and feed additive product developments and registrations. This includes assessing the suitability of data for a European submission, as well as writing reports and dossiers for regulatory submissions, managing regulatory procedures, and responding to assessor’s questions on behalf of clients.

Book now

10-11 Mar 2020
10-11 Mar 2020 Rembrandt Hotel, London GBP 1,399.00
EUR 1,959.00
USD 2,182.00
+ VAT @ 20.00%
GBP 1,199.00
EUR 1,679.00
USD 1,870.00
Until 14 Feb*
Enrol now

* Note the early booking discount cannot be combined with any other offers or promotional code

You may also be interested in

Previous customers include...

  • Aratana Therapeutics NV
  • Benchmark Animal Health
  • Benchmark Animal Health Ltd
  • Boehringer Ingelheim
  • Boehringer Ingelheim Animal Health GmbH
  • Boehringer Ingelheim Veterinary Research Center GmbH & Co. KG
  • Boehringer Ingelheim Veterinary Research Center GmbH &Co. KG
  • Boehringer Ingelheim Vetmedica GmbH
  • Boehringer Ingelheim Vetmedica Inc
  • CZ Veterinaria SA
  • Eco Animal Health Ltd
  • Elanco Animal Health
  • Fatro SpA
  • Hertape SA
  • Lohmann Animal Health
  • Lohmann Animal Health GmbH
  • Merial
  • National Drug Authority
  • Novartis, Centre de Recherche
  • Pharmaq AS
  • Research and Markets
  • Salfarm Danmark A/S
  • Semigator GmbH
  • Triveritas
  • VESO
  • Vetia Animal Health S.A.
  • Virbac Laboratories
  • ViroVet NV
  • Zoetis
  • Zoetis BV

Good approach to obtain an overview about regulatory affairs. Clear presentations.

Begoña Garcia Monelos, Regulatory Affairs Technician, CZ Veterinaria, S.A.

As you can imagine, the seminar content can be a bit arid for a scientist who is always dealing with lab experiments. Well, I was very surprised by how much the presenters had to share from their vast experience and made sure the course was not only presenting information. They were very dynamic, understood where the questions were coming from and always made sure we got our doubts clarified.

Maria del Rocio Leon Kempis, Head of Bacteriology, BIVRC GmbH Co. & KG

The course was really good, a lot of info packed into two days, but straight forward and logical. The course gave a good overview without going too much into specific details. The workshop was great and really helped a lot for understanding requirements better.

Sebastian Bubendorfer, Scientist, Boehringer Ingelheim Veterinary Research Center GmbH & Co. KG

The training was great, it fully met my expectations.

Louise Foster, Regulatory Manager, Semigator GmbH

Interesting and useful

Eleonora Bastino, Senior Associate Regulatory Affairs , Zoetis

Well presented in a cohesive structure - in the time. Content was adequately addresses and explained

Beverley Taylor, Senior Manager, Regulatory Affairs, Eco Animal Health Ltd

Great course. Would recommend. I appreciate that it is narrowed down to veterinary vaccine development in the EU. Most other courses I have come across covers many RA topics at once but this was more targeted. Even so, there was plenty of material to go through and we could get a bit more in depth.

Matias Nilsson, Regulatory Affairs Specialist & QPPV, Salfarm Danmark A/S

Interesting training, usefull for people not only from RA. Documentation complete and helpful.

Anna-Paola Colombo, Methods Process Improvement Specialist, Merial SAS

I am satisfied!

Ágnes Bárdi, Registration Expert, Ceva - Phylaxia Veterinary Biologicals co. Ltd.

The course was excellent insofar as it was tailored to individual needs and requirements. The materials provided are invaluable; they will help me with future projects. Overall a thoroughly enjoyable and useful training course.

Callum Scott, Vaccine Development Manager, Benchmark Animal Health Ltd

Very good opportunity

Luciano Gobbi, Associate Director Regulatory Affairs, MSD Animal Health SRL

Very interesting presentations and workshop to have a global overview of EU requirements and procedures

Charlène Ferrand, Global Regulatory Affairs Manager, Merial Business

Excellent

Marie Lovoll, Research Director, VESO

Very good and interesting

Amandine Bibard, Merial Business